Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load
HIV virulence, i.e. the time of progression to AIDS, varies greatly among patients. As for other rapidly evolving pathogens of humans, it is difficult to know if this variance is controlled by the genotype of the host or that of the virus because the transmission chain is usually unknown. We apply the phylogenetic comparative approach (PCA) to estimate the heritability of a trait from one infection to the next, which indicates the control of the virus genotype over this trait. The idea is to use viral RNA sequences obtained from patients infected by HIV-1 subtype B to build a phylogeny, which approximately reflects the transmission chain. Heritability is measured statistically as the propensity for patients close in the phylogeny to exhibit similar infection trait values. The approach reveals that up to half of the variance in set-point viral load, a trait associated with virulence, can be heritable. Our estimate is significant and robust to noise in the phylogeny. We also check for the consistency of our approach by showing that a trait related to drug resistance is almost entirely heritable. Finally, we show the importance of taking into account the transmission chain when estimating correlations between infection traits. The fact that HIV virulence is, at least partially, heritable from one infection to the next has clinical and epidemiological implications. The difference between earlier studies and ours comes from the quality of our dataset and from the power of the PCA, which can be applied to large datasets and accounts for within-host evolution. The PCA opens new perspectives for approaches linking clinical data and evolutionary biology because it can be extended to study other traits or other infectious diseases.
Vyšlo v časopise:
Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load. PLoS Pathog 6(9): e32767. doi:10.1371/journal.ppat.1001123
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001123
Souhrn
HIV virulence, i.e. the time of progression to AIDS, varies greatly among patients. As for other rapidly evolving pathogens of humans, it is difficult to know if this variance is controlled by the genotype of the host or that of the virus because the transmission chain is usually unknown. We apply the phylogenetic comparative approach (PCA) to estimate the heritability of a trait from one infection to the next, which indicates the control of the virus genotype over this trait. The idea is to use viral RNA sequences obtained from patients infected by HIV-1 subtype B to build a phylogeny, which approximately reflects the transmission chain. Heritability is measured statistically as the propensity for patients close in the phylogeny to exhibit similar infection trait values. The approach reveals that up to half of the variance in set-point viral load, a trait associated with virulence, can be heritable. Our estimate is significant and robust to noise in the phylogeny. We also check for the consistency of our approach by showing that a trait related to drug resistance is almost entirely heritable. Finally, we show the importance of taking into account the transmission chain when estimating correlations between infection traits. The fact that HIV virulence is, at least partially, heritable from one infection to the next has clinical and epidemiological implications. The difference between earlier studies and ours comes from the quality of our dataset and from the power of the PCA, which can be applied to large datasets and accounts for within-host evolution. The PCA opens new perspectives for approaches linking clinical data and evolutionary biology because it can be extended to study other traits or other infectious diseases.
Zdroje
1. BuchbinderSP
KatzMH
HessolNA
O'MalleyPM
HolmbergSD
1994 Long-term HIV-1 infection without immunologic progression. AIDS 8 1123 8
2. FellayJ
ShiannaKV
GeD
ColomboS
LedergerberB
2007 A whole-genome association study of major determinants for host control of HIV-1. Science 317 944 947
3. FellayJ
GeD
ShiannaKV
ColomboS
LedergerberB
2009 Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5 e1000791
4. WardJW
BushTJ
PerkinsHA
LiebLE
AllenJR
1989 The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med 321 947 52
5. AshtonLJ
LearmontJ
LuoK
WylieB
StewartG
1994 HIV infection in recipients of blood products from donors with known duration of infection. Lancet 344 718 20
6. IoannidisJPA
TatsioniA
AbramsEJ
BulterysM
CoombsRW
2004 Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis. AIDS 18 99 108
7. LynchM
WalshB
1998 Genetics and Analysis of Quantitative Traits Sunderland, MA, USA Sinauer Associates, Inc
8. HollingsworthTD
LaeyendeckerO
ShirreffG
DonnellyCA
SerwaddaD
2010 HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog 6 e1000876
9. TangJ
TangS
LobashevskyE
ZuluI
AldrovandiG
2004 HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. AIDS Res Hum Retroviruses 20 19 25
10. van der KuylAC
JurriaansS
PollakisG
BakkerM
CornelissenM
2010 HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. AIDS 24 1607 8
11. HechtFM
HartogensisW
BraggL
BacchettiP
AtchisonR
2010 HIV RNA level in early infection is predicted by viral load in the transmission source. AIDS 24 941 5
12. BlombergSP
GarlandTJ
IvesAR
2003 Testing for phylogenetic signal in comparative data: behavioral traits are more labile. Evolution 57 717 745
13. HousworthEA
MartinsEP
LynchM
2004 The phylogenetic mixed model. Am Nat 163 84 96
14. FelsensteinJ
2004 Inferring phylogenies Sunderland, MA, USA Sinauer Associates, Inc
15. The Swiss HIV Cohort Study 2010 Cohort Profile: The Swiss HIV Cohort Study. Int J Epidemiol in press doi:10.1093/ije/dyp321
16. FraserC
HollingsworthTD
ChapmanR
de WolfF
HanageWP
2007 Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc Natl Acad Sci USA 104 17441 17446
17. MüllerV
MaggioloF
SuterF
LadisaN
De LucaA
2009 Increasing clinical virulence in two decades of the Italian HIV epidemic. PLoS Pathog 5 e1000454
18. MellorsJW
RinaldoCRJ
GuptaP
WhiteRM
ToddJA
1996 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 1167 1170
19. LangfordSE
AnanworanichJ
CooperDA
2007 Predictors of disease progression in HIV infection: a review. AIDS Res Ther 4 11
20. MellorsJW
MargolickJB
PhairJP
RinaldoCR
DetelsR
2007 Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 297 2349 50
21. MellorsJW
MuñozA
GiorgiJV
MargolickJB
TassoniCJ
1997 Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 126 946 54
22. LeitnerT
EscanillaD
FranzenC
UhlenM
AlbertJ
1996 Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis. Proc Natl Acad Sci USA 93 10864 10869
23. HuéS
ClewleyJP
CanePA
PillayD
2004 HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 18 719 728
24. FelsensteinJ
1985 Phylogenies and the Comparative Method. Am Nat 125 1 15
25. KouyosRD
von WylV
YerlyS
BöniJ
TafféP
2010 Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. J Infect Dis 201 1488 97
26. FreckletonRP
HarveyPH
PagelM
2002 Phylogenetic analysis and comparative data: a test and review of evidence. Am Nat 160 712 726
27. FreckletonRP
2009 The seven deadly sins of comparative analysis. J Evol Biol 22 1367 75
28. RodríguezB
SethiAK
CheruvuVK
MackayW
BoschRJ
2006 Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296 1498 1506
29. KankiPJ
HamelDJ
SankaléJL
HsiehCc
ThiorI
1999 Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis 179 68 73
30. AriënKK
VanhamG
ArtsEJ
2007 Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 5 141 151
31. TaylorBS
SobieszczykME
McCutchanFE
HammerSM
2008 The challenge of HIV-1 subtype diversity. N Engl J Med 358 1590 602
32. GoldsteinS
OurmanovI
BrownCR
PlishkaR
Buckler-WhiteA
2005 Plateau levels of viremia correlate with the degree of CD4+-T-cell loss in simian immunodeficiency virus SIVagm-infected pigtailed macaques: variable pathogenicity of natural SIVagm isolates. J Virol 79 5153 5162
33. RambautA
PosadaD
CrandallKA
HolmesEC
2004 The causes and consequences of HIV evolution. Nat Rev Genet 5 52 61
34. AndersonRM
MayRM
1982 Coevolution of hosts and parasites. Parasitology 85 411 426
35. BonhoefferS
FunkGA
GunthardHF
FischerM
MullerV
2003 Glancing behind virus load variation in HIV-1 infection. Trends Microbiol 11 499 504
36. HollingsworthTD
AndersonRM
FraserC
2008 HIV-1 transmission, by stage of infection. J Infect Dis 198 687 693
37. KeetIP
VeugelersPJ
KootM
de WeerdMH
RoosMT
1996 Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. AIDS 10 1601 2
38. AriënKK
TroyerRM
GaliY
ColebundersRL
ArtsEJ
2005 Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS 19 1555 64
39. SiniccoA
ForaR
RaiteriR
SciandraM
BechisG
1997 Is the clinical course of HIV-1 changing? Cohort study. Brit Med J 314 1232 7
40. VanhemsP
LambertJ
GuerraM
HirschelB
AllardR
1999 Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. J Infect Dis 180 1803 8
41. DorrucciM
RezzaG
PorterK
PhillipsA
Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration 2007 Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis 195 525 34
42. GrasL
JurriaansS
BakkerM
van SighemA
BezemerD
2009 Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One 4 e7365
43. HolmbergSD
ConleyLJ
LubySP
CohnS
WongLC
1995 Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 9 291 6
44. O'BrienTR
HooverDR
RosenbergPS
ChenB
DetelsR
1995 Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. Am J Epidemiol 142 636 42
45. CASCADE Collaboration 2000 Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355 1131 7
46. CASCADE Collaboration 2003 Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 34 76 83
47. MüllerV
LedergerberB
PerrinL
KlimkaitT
FurrerH
2006 Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 20 889 894
48. HerbeckJT
GottliebGS
LiX
HuZ
DetelsR
2008 Lack of evidence for changing virulence of HIV-1 in North America. PLoS ONE 3 e1525
49. TroudeP
ChaixML
TranL
DeveauC
SengR
2009 No evidence of a change in HIV-1 virulence since 1996 in France. AIDS 23 1261 7
50. TrachtenbergE
KorberB
SollarsC
KeplerTB
HraberPT
2003 Advantage of rare HLA supertype in HIV disease progression. Nat Med 9 928 35
51. GoulderPJR
WatkinsDI
2008 Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 8 619 30
52. ParkerJ
RambautA
PybusOG
2008 Correlating viral phenotypes with phylogeny: Accounting for phylogenetic uncertainty. Infect Genet Evol 8 239 246
53. LemeyP
Kosakovsky PondSL
DrummondAJ
PybusOG
ShapiroB
2007 Synonymous substitution rates predict HIV disease progression as a result of underlying replication dynamics. PLoS Comput Biol 3 e29
54. RiederP
JoosB
von WylV
KusterH
GrubeC
2010 HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men. AIDS 24 1177 1183
55. LedergerberB
von OverbeckJ
EggerM
LuthyR
1994 The Swiss HIV Cohort Study: rationale, organization and selected baseline characteristics. Soz Praventivmed 39 387 394
56. von WylV
YerlyS
BöniJ
BürgisserP
KlimkaitT
2007 Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med 167 1782 90
57. WolbersM
BucherHC
FurrerH
RickenbachM
CavassiniM
2008 Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 9 397 405
58. RaboudJM
MontanerJS
ConwayB
HaleyL
SherlockC
1996 Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection. J Infect Dis 174 191 4
59. LylesRH
MuñozA
YamashitaTE
BazmiH
DetelsR
2000 Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis 181 872 80
60. BeerenwinkelN
DäumerM
OetteM
KornK
HoffmannD
2003 Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes. Nucleic Acids Res 31 3850 5
61. PagelM
1994 Detecting correlated evolution on phylogenies: a general method for the comparative analysis of discrete characters. Proc R Soc Lond B 255 37 45
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 9
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens
- The Length of Vesicular Stomatitis Virus Particles Dictates a Need for Actin Assembly during Clathrin-Dependent Endocytosis
- Inhibition of TIR Domain Signaling by TcpC: MyD88-Dependent and Independent Effects on Virulence
- Cellular Entry of Ebola Virus Involves Uptake by a Macropinocytosis-Like Mechanism and Subsequent Trafficking through Early and Late Endosomes